End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.11 USD | -.--% | -.--% | +10.00% |
Valuation
Fiscal Period: December | 2021 | 2022 |
---|---|---|
Capitalization 1 | 80 | 27.36 |
Enterprise Value (EV) 1 | 77.77 | 27.34 |
P/E ratio | -17.8 x | -9.17 x |
Yield | - | - |
Capitalization / Revenue | - | - |
EV / Revenue | - | - |
EV / EBITDA | -23,532,521 x | -9,351,910 x |
EV / FCF | -94,659,106 x | -26,030,617 x |
FCF Yield | -0% | -0% |
Price to Book | 36.5 x | -111 x |
Nbr of stocks (in thousands) | 74,762 | 74,762 |
Reference price 2 | 1.070 | 0.3660 |
Announcement Date | 22-03-31 | 23-03-31 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2020 | 2021 | 2022 |
---|---|---|---|
Net sales | - | - | - |
EBITDA | - | -3.399 | -2.926 |
EBIT 1 | -36.68 | -3.428 | -2.935 |
Operating Margin | - | - | - |
Earnings before Tax (EBT) 1 | -36.68 | -4.332 | -2.986 |
Net income 1 | -36.68 | -4.332 | -2.986 |
Net margin | - | - | - |
EPS 2 | -0.8996 | -0.0601 | -0.0399 |
Free Cash Flow | - | -0.8451 | -1.051 |
FCF margin | - | - | - |
FCF Conversion (EBITDA) | - | - | - |
FCF Conversion (Net income) | - | - | - |
Dividend per Share | - | - | - |
Announcement Date | 21-06-29 | 22-03-31 | 23-03-31 |
Balance Sheet Analysis
Fiscal Period: December | 2020 | 2021 | 2022 |
---|---|---|---|
Net Debt | - | - | - |
Net Cash position | - | 2.23 | 0.02 |
Leverage (Debt/EBITDA) | - | - | - |
Free Cash Flow | - | -0.85 | -1.05 |
ROE (net income / shareholders' equity) | - | -432% | -307% |
ROA (Net income/ Total Assets) | - | -168% | -140% |
Assets 1 | - | 2.586 | 2.13 |
Book Value Per Share 2 | -0 | 0.0300 | -0 |
Cash Flow per Share | - | 0.0300 | 0 |
Capex | - | 0.04 | - |
Capex / Sales | - | - | - |
Announcement Date | 21-06-29 | 22-03-31 | 23-03-31 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+10.00% | 8.22M | |
+25.69% | 47.86B | |
+46.90% | 41.42B | |
-3.46% | 40.66B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+28.07% | 12.14B | |
+0.17% | 12.15B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- BMND.F Stock
- Financials Biomind Labs Inc.